Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
Year: 2015
Type: conference-abstract
Abstract: Meeting abstracts STAT3 transcription factor is persistently activated in cancer cells and in diverse tumor-associated immune cells being an important oncogene and an essential immune checkpoint regulator. It is a highly desirable but challenging therapeutic target for pharmacological intervention
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2241195064